{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T04:05:00Z","timestamp":1790309100816,"version":"4.1.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,1,11]],"date-time":"2021-01-11T00:00:00Z","timestamp":1610323200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,11]],"date-time":"2021-01-11T00:00:00Z","timestamp":1610323200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100006191","name":"Eski\u015fehir Osmangazi \u00dcniversitesi","doi-asserted-by":"crossref","award":["201811D21"],"award-info":[{"award-number":["201811D21"]}],"id":[{"id":"10.13039\/501100006191","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s11064-020-03216-7","type":"journal-article","created":{"date-parts":[[2021,1,11]],"date-time":"2021-01-11T06:05:40Z","timestamp":1610345140000},"page":"804-818","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Ex Vivo Investigation of Bexarotene and Nicotinamide Function as a Protect\u0131ve Agent on Rat Synaptosomes Treated with A\u03b2(1-42)"],"prefix":"10.1007","volume":"46","author":[{"given":"Ceyhan","family":"Hacioglu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatih","family":"Kar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gungor","family":"Kanbak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,11]]},"reference":[{"key":"3216_CR1","doi-asserted-by":"publisher","first-page":"15056","DOI":"10.1038\/nrdp.2015.56","volume":"1","author":"CL Masters","year":"2015","unstructured":"Masters CL, Bateman R, Blennow K, Rowe CC, Sperling RA, Cummings JL (2015) Alzheimer\u2019s disease. Nat Rev Dis 1:15056. https:\/\/doi.org\/10.1038\/nrdp.2015.56","journal-title":"Nat Rev Dis"},{"issue":"1","key":"3216_CR2","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s40478-014-0146-2","volume":"2","author":"HC Tai","year":"2014","unstructured":"Tai HC, Wang BY, Serrano-Pozo A, Frosch MP, Spires-Jones TL, Hyman BT (2014) Frequent and symmetric deposition of misfolded tau oligomers within presynaptic and postsynaptic terminals in Alzheimer\u2019s disease. Acta Neuropathol Commun 2(1):146. https:\/\/doi.org\/10.1186\/s40478-014-0146-2","journal-title":"Acta Neuropathol Commun"},{"issue":"9","key":"3216_CR3","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/BF01181319","volume":"22","author":"VP Whittaker","year":"1993","unstructured":"Whittaker VP (1993) Thirty years of synaptosome research. J Neurocytol 22(9):735\u2013742. https:\/\/doi.org\/10.1007\/BF01181319","journal-title":"J Neurocytol"},{"issue":"6","key":"3216_CR4","doi-asserted-by":"publisher","first-page":"525","DOI":"10.2174\/156720508786898451","volume":"5","author":"B Su","year":"2008","unstructured":"Su B, Wang X, Nunomura A, Moreira PI, Lee HG, Perry G, Smith MA, Zhu X (2008) Oxidative stress signaling in Alzheimer\u2019s disease. Curr Alzheimer Res 5(6):525\u2013532. https:\/\/doi.org\/10.2174\/156720508786898451","journal-title":"Curr Alzheimer Res"},{"issue":"8","key":"3216_CR5","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1089\/ars.2012.5027","volume":"19","author":"DA Butterfield","year":"2013","unstructured":"Butterfield DA, Swomley AM, Sultana R (2013) Amyloid \u03b2-peptide (1\u201342)-induced oxidative stress in Alzheimer disease: importance in disease pathogenesis and progression. Antioxid Redox Signal 19(8):823\u2013835. https:\/\/doi.org\/10.1089\/ars.2012.5027","journal-title":"Antioxid Redox Signal"},{"issue":"1","key":"3216_CR6","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1756-6606-5-15","volume":"5","author":"Z Li","year":"2012","unstructured":"Li Z, Sheng M (2012) Caspases in synaptic plasticity. Mol Brain 5(1):15. https:\/\/doi.org\/10.1186\/1756-6606-5-15","journal-title":"Mol Brain"},{"issue":"1","key":"3216_CR7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3233\/JAD-2010-1215","volume":"19","author":"D Albani","year":"2010","unstructured":"Albani D, Polito L, Forloni G (2010) Sirtuins as novel targets for Alzheimer\u2019s disease and other neurodegenerative disorders: experimental and genetic evidence. J Alzheimers Dis 19(1):11\u201326. https:\/\/doi.org\/10.3233\/JAD-2010-1215","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"3216_CR8","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.molcel.2010.06.017","volume":"39","author":"R Krishnakumar","year":"2010","unstructured":"Krishnakumar R, Kraus WL (2010) The PARP side of the nucleus: molecular actions, physiological outcomes, and clinical targets. Mol Cell 39(1):8\u201324. https:\/\/doi.org\/10.1016\/j.molcel.2010.06.017","journal-title":"Mol Cell"},{"issue":"1","key":"3216_CR9","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.bcp.2014.06.021","volume":"92","author":"F Aredia","year":"2014","unstructured":"Aredia F, Scovassi AI (2014) Poly (ADP-ribose): a signaling molecule in different paradigms of cell death. Biochem Pharmacol 92(1):157\u2013163. https:\/\/doi.org\/10.1016\/j.bcp.2014.06.021","journal-title":"Biochem Pharmacol"},{"issue":"7","key":"3216_CR10","doi-asserted-by":"publisher","first-page":"733","DOI":"10.2174\/1389450111314070003","volume":"14","author":"HM Yonutas","year":"2013","unstructured":"Yonutas HM, Sullivan PG (2013) Targeting PPAR isoforms following CNS injury. Curr Drug Targets 14(7):733\u2013742. https:\/\/doi.org\/10.2174\/1389450111314070003","journal-title":"Curr Drug Targets"},{"issue":"12","key":"3216_CR11","doi-asserted-by":"publisher","first-page":"e448","DOI":"10.1038\/cddis.2012.189","volume":"3","author":"F Masciopinto","year":"2012","unstructured":"Masciopinto F, Di Pietro N, Corona C, Bomba M, Pipino C, Curcio M, Di Castelnuovo A, Ciavardelli D, Silvestri E, Canzoniero LM, Sekler I, Pandolfi A, Sensi SL (2012) Effects of long-term treatment with pioglitazone on cognition and glucose metabolism of PS1-KI, 3xTg-AD, and wild-type mice. Cell Death Dis 3(12):e448. https:\/\/doi.org\/10.1038\/cddis.2012.189","journal-title":"Cell Death Dis"},{"issue":"3","key":"3216_CR12","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1111\/j.1365-2133.2007.07975.x","volume":"157","author":"R Gniadecki","year":"2007","unstructured":"Gniadecki R, Assaf C, Bagot M, Dummer R, Duvic M, Knobler R, Ranki A, Schwandt P, Whittaker S (2007) The optimal use of bexarotene in cutaneous T-cell lymphoma. Br J Dermatol 157(3):433\u2013440. https:\/\/doi.org\/10.1111\/j.1365-2133.2007.07975.x","journal-title":"Br J Dermatol"},{"issue":"6075","key":"3216_CR13","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1126\/science","volume":"335","author":"PE Cramer","year":"2012","unstructured":"Cramer PE, Cirrito JR, Wesson DW, Lee CD, Karlo JC, Zinn AE, Casali BT, Restivo JL, Goebel WD, James MJ, Brunden KR, Wilson DA, Landreth GE (2012) ApoE-directed therapeutics rapidly clear \u03b2-amyloid and reverse deficits in AD mouse models. Sci 335(6075):1503\u20131506. https:\/\/doi.org\/10.1126\/science","journal-title":"Sci"},{"issue":"44","key":"3216_CR14","doi-asserted-by":"publisher","first-page":"30538","DOI":"10.1074\/jbc.M114.600833","volume":"289","author":"LM Tai","year":"2014","unstructured":"Tai LM, Koster KP, Luo J, Lee SH, Wang YT, Collins NC, Ben Aissa M, Thatcher GR, LaDu MJ (2014) Amyloid-\u03b2 pathology and APOE genotype modulate retinoid X receptor agonist activity in vivo. Journal of Biological Chem 289(44):30538\u201330555. https:\/\/doi.org\/10.1074\/jbc.M114.600833","journal-title":"Journal of Biological Chem"},{"issue":"9","key":"3216_CR15","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1021\/acschemneuro.7b00107","volume":"8","author":"PDQ Huy","year":"2017","unstructured":"Huy PDQ, Thai NQ, Bednarikova Z, Phuc LH, Linh HQ, Gazova Z, Li MS (2017) Bexarotene does not clear amyloid beta plaques but delays fibril growth: Molecular mechanisms. ACS chemical neuroscience 8(9):1960\u20131969. https:\/\/doi.org\/10.1021\/acschemneuro.7b00107","journal-title":"ACS chemical neuroscience"},{"issue":"1","key":"3216_CR16","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.tibs.2006.11.006","volume":"32","author":"P Belenky","year":"2007","unstructured":"Belenky P, Bogan KL, Brenner C (2007) NAD+ metabolism in health and disease. Trends Biochem Sci 32(1):12\u201319. https:\/\/doi.org\/10.1016\/j.tibs.2006.11.006","journal-title":"Trends Biochem Sci"},{"issue":"45","key":"3216_CR17","doi-asserted-by":"publisher","first-page":"11500","DOI":"10.1523\/JNEUROSCI.3203-08.2008","volume":"28","author":"KN Green","year":"2008","unstructured":"Green KN, Steffan JS, Martinez-Coria H, Sun X, Schreiber SS, Thompson LM, LaFerla FM (2008) Nicotinamide restores cognition in Alzheimer\u2019s disease transgenic mice via a mechanism involving sirtuin inhibition and selective reduction of Thr231-phosphotau. J Neurosci 28(45):11500\u201311510. https:\/\/doi.org\/10.1523\/JNEUROSCI.3203-08.2008","journal-title":"J Neurosci"},{"issue":"7","key":"3216_CR18","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1002\/cbf.3049","volume":"32","author":"ET Bayrakdar","year":"2014","unstructured":"Bayrakdar ET, Armagan G, Uyanikgil Y, Kanit L, Koylu E, Yalcin A (2014) Ex vivo protective effects of nicotinamide and 3-aminobenzamide on rat synaptosomes treated with A\u03b2 (1\u201342). Cell Biochem Funct 32(7):557\u2013564. https:\/\/doi.org\/10.1002\/cbf.3049","journal-title":"Cell Biochem Funct"},{"issue":"1","key":"3216_CR19","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s10753-017-0691-5","volume":"41","author":"B Tunctan","year":"2018","unstructured":"Tunctan B, Kucukkavruk SP, Temiz-Resitoglu M, Guden DS, Sari AN, Sahan-Firat S (2018) Bexarotene, a selective RXR\u03b1 agonist, reverses hypotension associated with inflammation and tissue injury in a rat model of septic shock. Inflammation 41(1):337\u2013355. https:\/\/doi.org\/10.1007\/s10753-017-0691-5","journal-title":"Inflammation"},{"issue":"1","key":"3216_CR20","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/ng1718","volume":"38","author":"A Rovelet-Lecrux","year":"2006","unstructured":"Rovelet-Lecrux A, Hannequin D, Raux G, Le Meur N, Laquerriere A, Vital A, Dumanchin C, Feuillette S, Brice A, Vercelletto M, Dubas F, Frebourg T, Campion D (2006) APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy. Nat Genet 38(1):24\u201326. https:\/\/doi.org\/10.1038\/ng1718","journal-title":"Nat Genet"},{"issue":"2","key":"3216_CR21","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1042\/bj0900293","volume":"90","author":"VP Whittaker","year":"1964","unstructured":"Whittaker VP, Michaelson I, Kirkland RJA (1964) The separation of synaptic vesicles from nerve-ending particles (synaptosomes\u2019). Biochem J 90(2):293. https:\/\/doi.org\/10.1042\/bj0900293","journal-title":"Biochem J"},{"issue":"1","key":"3216_CR22","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","volume":"193","author":"OH Lowry","year":"1951","unstructured":"Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ (1951) Protein Measurement with the Folin-Phenol Reagent. J Biol Chem 193(1):265\u2013375","journal-title":"J Biol Chem"},{"key":"3216_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ab.2016.10.015","volume":"517","author":"P Tenreiro","year":"2017","unstructured":"Tenreiro P, Rebelo S, Martins F, Santos M, Coelho ED, Almeida M, Matos AAD, e Silva ODC (2017) Comparison of simple sucrose and percoll based methodologies for synaptosome enrichment. Anal Biochem 517:1\u20138. https:\/\/doi.org\/10.1016\/j.ab.2016.10.015","journal-title":"Anal Biochem"},{"issue":"3","key":"3216_CR24","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1002\/cyto.a.22009","volume":"81","author":"S Sokolow","year":"2012","unstructured":"Sokolow S, Henkins KM, Williams IA, Vinters HV, Schmid I, Cole GM, Gylys KH (2012) Isolation of synaptic terminals from Alzheimer\u2019s disease cortex. Cytometry Part A 81(3):248\u2013254. https:\/\/doi.org\/10.1002\/cyto.a.22009","journal-title":"Cytometry Part A"},{"issue":"11","key":"3216_CR25","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1038\/nprot.2008.171","volume":"3","author":"PR Dunkley","year":"2008","unstructured":"Dunkley PR, Jarvie PE, Robinson PJ (2008) A rapid Percoll gradient procedure for preparation of synaptosomes. Nat Protoc 3(11):1718. https:\/\/doi.org\/10.1038\/nprot.2008.171","journal-title":"Nat Protoc"},{"issue":"1\u20132","key":"3216_CR26","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/0006-8993(81)91086-6","volume":"226","author":"PR Dodd","year":"1981","unstructured":"Dodd PR, Hardy JA, Oakley AE, Edwardson JA, Perry EK, Delaunoy JP (1981) A rapid method for preparing synaptosomes: comparison, with alternative procedures. Brain Res 226(1\u20132):107\u2013118. https:\/\/doi.org\/10.1016\/0006-8993(81)91086-6","journal-title":"Brain Res"},{"issue":"1","key":"3216_CR27","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/bf00969765","volume":"14","author":"AD Sherman","year":"1989","unstructured":"Sherman AD (1989) Isolation of metabolically distinct synaptosomes on Percoll gradients. Neurochem Res 14(1):97\u2013101. https:\/\/doi.org\/10.1007\/bf00969765","journal-title":"Neurochem Res"},{"key":"3216_CR28","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/978-1-4020-5943-8_6","volume":"3","author":"F Bai","year":"2007","unstructured":"Bai F, Witzmann FA (2007) Synaptosome proteomics. Subcell Biochem 3:77\u201398. https:\/\/doi.org\/10.1007\/978-1-4020-5943-8_6","journal-title":"Subcell Biochem"},{"issue":"2","key":"3216_CR29","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1385\/NMM:2:2:215","volume":"2","author":"MP Mattson","year":"2002","unstructured":"Mattson MP, Liu D (2002) Energetics and oxidative stress in synaptic plasticity and neurodegenerative disorders. Neuromolecular Med 2(2):215\u2013231. https:\/\/doi.org\/10.1385\/NMM:2:2:215","journal-title":"Neuromolecular Med"},{"key":"3216_CR30","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.bbadis.2011.10.003","volume":"5","author":"CB Pocernich","year":"1822","unstructured":"Pocernich CB (1822) Butterfield DA (2012) Elevation of glutathione as a therapeutic strategy in Alzheimer disease. Biochim Biophys Acta 5:625\u2013630. https:\/\/doi.org\/10.1016\/j.bbadis.2011.10.003","journal-title":"Biochim Biophys Acta"},{"issue":"12","key":"3216_CR31","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.tips.2008.09.001","volume":"29","author":"D Pratico","year":"2008","unstructured":"Pratico D (2008) Oxidative stress hypothesis in Alzheimer\u2019s disease: a reappraisal. Trends Neurosci 29(12):609\u2013615. https:\/\/doi.org\/10.1016\/j.tips.2008.09.001","journal-title":"Trends Neurosci"},{"issue":"2","key":"3216_CR32","doi-asserted-by":"publisher","first-page":"609","DOI":"10.3233\/JAD-2010-100564","volume":"20","author":"M Manczak","year":"2010","unstructured":"Manczak M, Mao P, Calkins MJ, Cornea A, Reddy AP, Murphy MP, Szeto HH, Park B, Reddy PH (2010) Mitochondria-targeted antioxidants protect against amyloid-\u03b2 toxicity in Alzheimer\u2019s disease neurons. J Alzheimers Dis 20(2):609\u2013631. https:\/\/doi.org\/10.3233\/JAD-2010-100564","journal-title":"J Alzheimers Dis"},{"key":"3216_CR33","doi-asserted-by":"publisher","first-page":"175062","DOI":"10.1155\/2014\/175062","volume":"2014","author":"J Hroudova","year":"2014","unstructured":"Hroudova J, Singh N, Fisar Z (2014) Mitochondrial dysfunctions in neurodegenerative diseases: relevance to Alzheimer\u2019s disease. Biomed Res Int 2014:175062. https:\/\/doi.org\/10.1155\/2014\/175062","journal-title":"Biomed Res Int"},{"issue":"5","key":"3216_CR34","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.2353\/ajpath.2008.080434","volume":"173","author":"N Louneva","year":"2008","unstructured":"Louneva N, Cohen JW, Han LY, Talbot K, Wilson RS, Bennett DA, Trojanowski JQ, Arnold SE (2008) Caspase-3 is enriched in postsynaptic densities and increased in Alzheimer\u2019s disease. Am J Pathol 173(5):1488\u20131495. https:\/\/doi.org\/10.2353\/ajpath.2008.080434","journal-title":"Am J Pathol"},{"key":"3216_CR35","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3389\/fncel.2015.00064","volume":"9","author":"F Ng","year":"2015","unstructured":"Ng F, Wijaya L, Tang BL (2015) SIRT1 in the brain\u2014connections with aging-associated disorders and lifespan. Front Cell Neurosci 9:64. https:\/\/doi.org\/10.3389\/fncel.2015.00064","journal-title":"Front Cell Neurosci"},{"issue":"9","key":"3216_CR36","doi-asserted-by":"publisher","first-page":"6823","DOI":"10.1074\/jbc.M609554200","volume":"282","author":"M Tanno","year":"2007","unstructured":"Tanno M, Sakamoto J, Miura T, Shimamoto K, Horio Y (2007) Nucleocytoplasmic shuttling of the NAD+-dependent histone deacetylase SIRT1. J Biol Chem 282(9):6823\u20136832. https:\/\/doi.org\/10.1074\/jbc.M609554200","journal-title":"J Biol Chem"},{"issue":"31","key":"3216_CR37","doi-asserted-by":"publisher","first-page":"21745","DOI":"10.1074\/jbc.M602909200","volume":"281","author":"W Qin","year":"2006","unstructured":"Qin W, Yang T, Ho L, Zhao Z, Wang J, Chen L, Zhao W, Thiyagarajan M, MacGrogan D, Rodgers JT, Puigserver P, Sadoshima J, Deng H, Pedrini S, Gandy S, Sauve AA, Pasinetti GM (2006) Neuronal SIRT1 activation as a novel mechanism underlying the prevention of Alzheimer disease amyloid neuropathology by calorie restriction. J Biol Chem 281(31):21745\u201321754. https:\/\/doi.org\/10.1074\/jbc.M602909200","journal-title":"J Biol Chem"},{"issue":"1","key":"3216_CR38","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1097\/NEN.0b013e3181922348","volume":"68","author":"C Julien","year":"2009","unstructured":"Julien C, Tremblay C, Emond V, Lebbadi M, JrN S, Bennett DA, Calon F (2009) Sirtuin 1 reduction parallels the accumulation of tau in Alzheimer disease. J Neuropathol Exp 68(1):48\u201358. https:\/\/doi.org\/10.1097\/NEN.0b013e3181922348","journal-title":"J Neuropathol Exp"},{"issue":"12","key":"3216_CR39","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1089\/ars.2011.4400","volume":"16","author":"K Schmitt","year":"2012","unstructured":"Schmitt K, Grimm A, Kazmierczak A, Strosznajder JB, G\u00f6tz J, Eckert A (2012) Insights into mitochondrial dysfunction: aging, amyloid-\u03b2, and tau\u2013a deleterious trio. Antioxid Redox Signal 16(12):1456\u20131466. https:\/\/doi.org\/10.1089\/ars.2011.4400","journal-title":"Antioxid Redox Signal"},{"issue":"1","key":"3216_CR40","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s12035-012-8258-9","volume":"46","author":"JB Strosznajder","year":"2012","unstructured":"Strosznajder JB, Czapski GA, Adamczyk A, Strosznajder RP (2012) Poly (ADP-ribose) polymerase-1 in amyloid beta toxicity and Alzheimer\u2019s disease. Mol Neurobiol 46(1):78\u201384. https:\/\/doi.org\/10.1007\/s12035-012-8258-9","journal-title":"Mol Neurobiol"},{"issue":"2","key":"3216_CR41","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3233\/jad-2006-9209","volume":"9","author":"SM de la Monte","year":"2006","unstructured":"de la Monte SM, Wands JR (2006) Molecular indices of oxidative stress and mitochondrial dysfunction occur early and often progress with severity of Alzheimer\u2019s disease. J Alzheimer\u2019s Dis 9(2):167\u2013181. https:\/\/doi.org\/10.3233\/jad-2006-9209","journal-title":"J Alzheimer's Dis"},{"key":"3216_CR42","doi-asserted-by":"publisher","first-page":"239","DOI":"10.3389\/fncel.2019.00239","volume":"13","author":"S Moosecker","year":"2019","unstructured":"Moosecker S, Gomes PA, Dioli C, Yu S, Sotiropoulos I, Almeida OF (2019) Activated PPAR\u03b3 abrogates misprocessing of amyloid precursor protein, Tau missorting and synaptotoxicity. Front Cell Neurosci 13:239. https:\/\/doi.org\/10.3389\/fncel.2019.00239","journal-title":"Front Cell Neurosci"},{"issue":"1","key":"3216_CR43","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.yexcr.2004.09.032","volume":"304","author":"NC Inestrosa","year":"2005","unstructured":"Inestrosa NC, Godoy JA, Quintanilla RA, Koenig CS, Bronfman M (2005) Peroxisome proliferator-activated receptor \u03b3 is expressed in hippocampal neurons and its activation prevents \u03b2-amyloid neurodegeneration: role of Wnt signaling. Exp Cell Res 304(1):91\u2013104. https:\/\/doi.org\/10.1016\/j.yexcr.2004.09.032","journal-title":"Exp Cell Res"},{"issue":"4","key":"3216_CR44","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/s0092-8674(04)00416-7","volume":"117","author":"P Bieganowski","year":"2004","unstructured":"Bieganowski P, Brenner C (2004) Discoveries of nicotinamide riboside as a nutrient and conserved NRK genes establish a Preiss-Handler independent route to NAD+ in fungi and humans. Cell 117(4):495\u2013502. https:\/\/doi.org\/10.1016\/s0092-8674(04)00416-7","journal-title":"Cell"},{"issue":"1","key":"3216_CR45","first-page":"27","volume":"30","author":"V Demarin","year":"2004","unstructured":"Demarin V, Podobnik SS, Storga-Tomic D, Kay G (2004) Treatment of Alzheimer\u2019s disease with stabilized oral nicotinamide adenine dinucleotide: a randomized, double-blind study. Drugs Exp Clin Res 30(1):27\u201333","journal-title":"Drugs Exp Clin Res"},{"issue":"1","key":"3216_CR46","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s12017-009-8058-1","volume":"11","author":"D Liu","year":"2009","unstructured":"Liu D, Gharavi R, Pitta M, Gleichmann M, Mattson MP (2009) Nicotinamide prevents NAD+ depletion and protects neurons against excitotoxicity and cerebral ischemia: NAD+ consumption by SIRT1 may endanger energetically compromised neurons. Neuromol Med 11(1):28\u201342. https:\/\/doi.org\/10.1007\/s12017-009-8058-1","journal-title":"Neuromol Med"},{"issue":"1","key":"3216_CR47","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.molcel.2007.07.032","volume":"28","author":"X Li","year":"2007","unstructured":"Li X, Zhang S, Blander G, Jeanette GT, Krieger M, Guarente L (2007) SIRT1 deacetylates and positively regulates the nuclear receptor LXR. Mol Cell 28(1):91\u2013106. https:\/\/doi.org\/10.1016\/j.molcel.2007.07.032","journal-title":"Mol Cell"},{"key":"3216_CR48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0072169","author":"S Martire","year":"2013","unstructured":"Martire S, Fuso A, Rotili D, Tempera I, Giordano C, De Zottis I, Muzi A, Vernole P, Graziani G, Lococo E, Faraldi M, Maras B, Scarpa S, Mosca L, d\u2019Erme M (2013) PARP-1 modulates amyloid beta peptide-induced neuronal damage. PLoS ONE. https:\/\/doi.org\/10.1371\/journal.pone.0072169","journal-title":"PLoS ONE"},{"issue":"1","key":"3216_CR49","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.ab.2009.07.019","volume":"394","author":"BC Smith","year":"2009","unstructured":"Smith BC, Hallows WC, Denu JM (2009) A continuous microplate assay for sirtuins and nicotinamide-producing enzymes. Anal Biochem 394(1):101\u2013109. https:\/\/doi.org\/10.1016\/j.ab.2009.07.019","journal-title":"Anal Biochem"},{"issue":"4","key":"3216_CR50","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.cmet.2011.03.004","volume":"13","author":"P Bai","year":"2011","unstructured":"Bai P, Canto C, Oudart H, Brunyanszki A, Cen Y, Thomas C, Yamamoto H, Huber A, Kiss B, Houtkooper RH, Schoonjans K, Schreiber V, Sauve AA, Menissier-de Murcia J, Auwerx J (2011) PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation. Cell Metab 13(4):461\u2013468. https:\/\/doi.org\/10.1016\/j.cmet.2011.03.004","journal-title":"Cell Metab"},{"issue":"3","key":"3216_CR51","doi-asserted-by":"publisher","first-page":"849","DOI":"10.3233\/JAD-150469","volume":"48","author":"M Kuntz","year":"2015","unstructured":"Kuntz M, Candela P, Saint-Pol J, Lamartiniere Y, Boucau MC, Sevin E, Fenart L, Gosselet F (2015) Bexarotene promotes cholesterol efflux and restricts apical-to-basolateral transport of amyloid-\u03b2 peptides in an in vitro model of the human blood-brain barrier. J Alzheimer\u2019s Dis 48(3):849\u2013862. https:\/\/doi.org\/10.3233\/JAD-150469","journal-title":"J Alzheimer's Dis"},{"issue":"2","key":"3216_CR52","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1073\/pnas.0503839103","volume":"103","author":"M Sastre","year":"2006","unstructured":"Sastre M, Dewachter I, Rossner S, Bogdanovic N, Rosen E, Borghgraef P, Evert BO, Dumitrescu-Ozimek L, Thal DR, Landreth G, Walter J, Klockgether T, van Leuven F, Heneka MT (2006) Nonsteroidal anti-inflammatory drugs repress \u03b2-secretase gene promoter activity by the activation of PPAR\u03b3. Proc Natl Acad Sci USA 103(2):443\u2013448. https:\/\/doi.org\/10.1073\/pnas.0503839103","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"3216_CR53","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.trci.2016.06.001","volume":"2","author":"K Ghosal","year":"2016","unstructured":"Ghosal K, Haag M, Verghese PB, West T, Veenstra T, Braunstein JB, Bateman RJ, Holtzman DM, Landreth GE (2016) A randomized controlled study to evaluate the effect of bexarotene on amyloid-\u03b2 and apolipoprotein E metabolism in healthy subjects. Alzheimers Dement (NY) 2(2):110\u2013120. https:\/\/doi.org\/10.1016\/j.trci.2016.06.001","journal-title":"Alzheimers Dement (NY)"},{"issue":"5","key":"3216_CR54","doi-asserted-by":"publisher","first-page":"687","DOI":"10.3390\/biom10050687","volume":"10","author":"ES Hwang","year":"2020","unstructured":"Hwang ES, Song SB (2020) Possible adverse effects of high-dose nicotinamide: mechanisms and safety assessment. Biomolecules 10(5):687. https:\/\/doi.org\/10.3390\/biom10050687","journal-title":"Biomolecules"},{"issue":"9","key":"3216_CR55","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1200\/JCO.2001.19.9.2456","volume":"19","author":"M Duvic","year":"2001","unstructured":"Duvic M, Hymes K, Heald P, Breneman D, Martin AG, Myskowski P, Crowley C, Yocum RC, Bexarotene Worldwide Study Group (2001) Bexarotene is effective and safe for treatment of refractory advanced-stage cutaneous T-cell lymphoma: multinational phase II-III trial results. J Clin Oncol 19(9):2456\u201371. https:\/\/doi.org\/10.1200\/JCO.2001.19.9.2456","journal-title":"J Clin Oncol"},{"issue":"6075","key":"3216_CR56","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1126\/science","volume":"335","author":"PE Cramer","year":"2012","unstructured":"Cramer PE, Cirrito JR, Wesson DW, Lee CD, Karlo JC, Zinn AE, Casali BT, Restivo JL, Goebel WD, James MJ, Brunden KR, Wilson DA, Landreth GE (2012) ApoE-directed therapeutics rapidly clear \u03b2-amyloid and reverse deficits in AD mouse models. Science 335(6075):1503\u20131506. https:\/\/doi.org\/10.1126\/science","journal-title":"Science"},{"issue":"21","key":"3216_CR57","doi-asserted-by":"publisher","first-page":"7458","DOI":"10.1093\/nar\/gkq609","volume":"38","author":"L Han","year":"2010","unstructured":"Han L, Zhou R, Niu J, McNutt MA, Wang P, Tong T (2010) SIRT1 is regulated by a PPAR\u03b3\u2013SIRT1 negative feedback loop associated with senescence. Nucleic Acids Res 38(21):7458\u20137471. https:\/\/doi.org\/10.1093\/nar\/gkq609","journal-title":"Nucleic Acids Res"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-020-03216-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11064-020-03216-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-020-03216-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T16:25:39Z","timestamp":1615393539000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11064-020-03216-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,11]]},"references-count":57,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["3216"],"URL":"https:\/\/doi.org\/10.1007\/s11064-020-03216-7","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,11]]},"assertion":[{"value":"16 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that there are no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}